- Taiwan
- /
- Electronic Equipment and Components
- /
- TWSE:3030
Test Research Second Quarter 2024 Earnings: EPS: NT$1.97 (vs NT$0.87 in 2Q 2023)
Test Research (TWSE:3030) Second Quarter 2024 Results
Key Financial Results
- Revenue: NT$1.73b (up 85% from 2Q 2023).
- Net income: NT$466.1m (up 126% from 2Q 2023).
- Profit margin: 27% (up from 22% in 2Q 2023). The increase in margin was driven by higher revenue.
- EPS: NT$1.97 (up from NT$0.87 in 2Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Test Research shares are up 23% from a week ago.
Risk Analysis
Don't forget that there may still be risks. For instance, we've identified 2 warning signs for Test Research (1 is a bit unpleasant) you should be aware of.
Valuation is complex, but we're here to simplify it.
Discover if Test Research might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About TWSE:3030
Test Research
Designs, assembles, manufactures, sells, and maintains automated inspection and testing equipment in Asia, the United States, Europe, and internationally.
Flawless balance sheet with solid track record.